Last edition
News about "Pharma Funding"
Cue Biopharma Prices USD 10 Million Public Offering
Cue Biopharma has priced a USD 10 million public offering, with gross proceeds expected to be approximately USD 10 million before underwriting discounts, commissions, and other offering-related expenses.
Pharma Funding | 20/12/2025 | By News Bureau
Virax Biolabs Closes USD 5 Million Private Placement
Virax Biolabs has closed a USD 5 million private placement, extending its cash runway into the first half of 2028 and supporting ongoing regulatory studies for its ViraxImmune platform, including long COVID and post-acute infection syndrome programmes, alongside planned FDA and MHRA submissions and platform expansion initiatives.
Pharma Funding | 06/12/2025 | By Dineshwori
Rubicon Research, a pharmaceutical formulations company, has announced that in a pre-IPO transaction, General Atlantic Singapore RR transferred 2.889 million equity shares to TIMF Holdings and 360 ONE funds at INR 484.47 per share, aggregating to INR 140 crore.
Pharma Funding | 22/09/2025 | By Darshana | 406
Alchemab Launches First-in-Human Trial of ATLX-1282, Secures 32 Million USD Financing Boost
Alchemab Therapeutics, a biopharmaceutical company that develops naturally occurring therapeutic antibodies from resilient individuals, has announced the initiation of its first-in-human phase 1 study of ATLX-1282.
Pharma Funding | 10/09/2025 | By Darshana | 261
US govt to provide $52.9 M to Virginia to boost pharma manufacturing
The money will be utilised to expand the domestic supply chain for essential medicines and active pharmaceutical ingredients
Pharma Funding | 12/09/2022 | By Sudeep Soparkar | 717
Govt grants in-principle approval to set up bulk drug park in Una, HP
The scheme for the promotion of bulk drug park is expected to result in incremental production of bulk drugs worth about Rs 46,400 crore
Pharma Funding | 01/09/2022 | By Sudeep Soparkar | 935
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy